ArticleExperimental hematology & oncology2021

Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine.

Sophie Voruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.